NCT05527626Recruiting
Chronic Kidney Disease - REAL Life Study in Alsace
Source: ClinicalTrials.gov · Last updated 9 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry). Real-life data are essential to specify the characteristics of patients with chronic kidney disease and the factors associated with the evolution of CKD and the occurrence of complications in order to improve the management of CKD before the suppletion stage. Since October 2019, CKD at the severe stage (stage 4) and at the non-dialysis end stage (stage 5) is subject to an annual flat fee (Article L. 162-22-6-2 of the Social Security Code). The reimbursement of these lump sums by the health insurance is subject to the collection and transmission of certain medical data by the establishments.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 30 Aug 2022
- Start date
- 17 Feb 2022
- Primary completion date
- 1 Aug 2027
- Lead sponsor
- University Hospital, Strasbourg, France
- Diseases
- Chronic kidney disease
- NCT number
- NCT05527626
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 17 Feb 2022 to the primary completion date, 1 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Subject having expressed his opposition to participate in the study
Who the study is looking for
- Major subject (≥18 years)
- Subject included in the MRC package (GFR \<30 ml/min/1.73 m2)
- Subject who has not expressed opposition, after information, to the reuse of his or her data for the purpose of this research
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France Coordinator of this site? Confirm its status | Strasbourg | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.